Philip W. Stather

Philip W. Stather

Auto-generated profile, based on publicly available information

Philip W. Stather

Department of Vascular Surgery, Norfolk and Norwich University Hospital, Norwich, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2013 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
PSP. W. Stather
P. W. Stather
DSD. Sidloff
D. Sidloff
NDN. Dattani
N. Dattani
ECE. Choke
E. Choke
MBM. J. Bown
M. J. Bown
RSR. D. Sayers
R. D. Sayers

1 October 2013 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Closed access
PDF file
PSPhilip W. Stather
Philip W. Stather
NSNicolas Sylvius
Nicolas Sylvius
JWJohn B. Wild
John B. Wild
ECEdward Choke
Edward Choke
RSRobert D. Sayers
Robert D. Sayers
MBMatthew J. Bown
Matthew J. Bown
Background—: Peripheral arterial disease (PAD) is a clinical condition caused by an atherosclerotic process affecting the arteries of the limbs. Despite major improvements in surgical endovascular techniques, PAD is still associated with high mortality and morbidity. Recently, microRNAs (miRNAs), a class of short noncoding RNA controlling gene expression, have emerged as major regulators of multiple biological processes. Methods and Results—: A whole-miRNA transcriptome profiling was performed in peripheral blood from an initial sample set of patients and controls. A 12-miRNA PAD-specific signature, which includes let 7e, miR-15b, -16, -20b, -25, -26b, -27b, -28-5p, -126, -195, -335, and -363, was further investigated and validated in 2 additional sample sets. Each of these 12 miRNAs exhibited good diagnostic value as evidenced by receiver operating characteristic curve analyses. Pathway enrichment analysis using predicted and validated targets identified several signaling pathways relevant to vascular disorders. Several of these pathways, including cell adhesion molecules, were confirmed by quantifying the expression level of several candidate genes regulating the initial stages of the inflammatory atherosclerotic process. The expression level of 7 of these candidate genes exhibits striking inverse correlation with that of several, if not all, of the miRNAs of the PAD-specific miRNA signature. Conclusions—: These results demonstrate the potential of miRNAs for the diagnosis of PAD and provide further insight into the molecular mechanisms leading to the development of PAD, with the potential for future therapeutic targets.

1 March 2014 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PSP.W. Stather
P.W. Stather
DSD.A. Sidloff
D.A. Sidloff
IRI.A. Rhema
I.A. Rhema
ECE. Choke
E. Choke
MBM.J. Bown
M.J. Bown
RSR.D. Sayers
R.D. Sayers

1 March 2013 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PSP.W. Stather
P.W. Stather
NDN. Dattani
N. Dattani
MBM.J. Bown
M.J. Bown
JEJ.J. Earnshaw
J.J. Earnshaw
TLT.A. Lees
T.A. Lees

18 August 2014 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
PSP. W. Stather
P. W. Stather
DSD A Sidloff
D A Sidloff
NDN. Dattani
N. Dattani
VGV. J. Gokani
V. J. Gokani
ECE. Choke
E. Choke
MBM. J. Bown
M. J. Bown

1 December 2012 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PSP.W. Stather
P.W. Stather
RSR.D. Sayers
R.D. Sayers
ACA. Cheah
A. Cheah
JWJ.B. Wild
J.B. Wild
MBM.J. Bown
M.J. Bown
ECE. Choke
E. Choke